Effect of S-Phase Kinase-Associated Protein 2 Expression on Distant Metastasis and Survival in Nasopharyngeal Carcinoma Patients

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 202-207

  Fang, Fu Min ^a   Chien, Chih Yen ^a   Li, Chien Feng ^b   Shiu, Wan Yu ^a   Chen, Chang Han ^a   Huang, Hsuan Ying ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Metastasis; Nasopharyngeal carcinoma; S phase kinase associated protein 2; Skp2; Survival

Indexed keywords

ENZYMES; PATHOLOGY; SHELTERS (FROM ATTACK);

METASTASIS; NASOPHARYNGEAL CARCINOMA; S-PHASE KINASE-ASSOCIATED PROTEIN 2; SKP2; SURVIVAL;

COMPUTER OPERATING SYSTEMS;

CYCLIN DEPENDENT KINASE INHIBITOR 1B; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DEGRADATION; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; S-PHASE KINASE-ASSOCIATED PROTEINS; SENSITIVITY AND SPECIFICITY; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 57649109825     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.008     Document Type: Article

References (24)

1. Fang F.M., Tsai W.L., Go S.F., et al. Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 961-969
2. In: Chan J., Plich B.Z., Kuo T.T., et al. (Eds). World Health Organization classification of tumors-Pathology & genetics: Head and neck tumors (2005), IARC Press, Lyon, France 85-97
3. Liu M.T., Hsieh C.Y., Chang T.H., et al. Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jap J Clin Oncol 33 (2003) 501-508
4. Borden E.C., Baker L.H., Bell R.S., et al. Soft tissue sarcomas of adults: State of the translational science. Clin Cancer Res 9 (2003) 1941-1956
5. Gstaiger M., Jordan R., Lim M., et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 98 (2001) 5043-5048
6. Jarnagin W.R., Klimstra D.S., Hezel M., et al. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: Correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24 (2006) 1152-1160
7. Hwang C.F., Su C.Y., Huang S.C., et al. Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma. Cancer Lett 189 (2003) 231-236
8. Sutterluty H., Chatelain E., Marti A., et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1 (1999) 207-214
9. Lim M.S., Adamson A., Lin Z., et al. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: Correlation with p27(Kip1) and proliferation index. Blood 100 (2002) 2950-2956
10. Huang H.Y., Kang H.Y., Li C.F., et al. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Clin Cancer Res 12 (2006) 487-498
11. Oliveira A.M., Okuno S.H., Nascimento A.G., et al. Skp2 protein expression in soft tissue sarcomas. J Clin Oncol 21 (2003) 722-727
12. Nasopharyngeal carcinoma. In: Cancer. American Joint Committee on Cancer, editor. Cancer staging manual. 6th ed. Philadelphia: Lippincott-Raven; 2002. p. 221-228.
13. Budwit-Novotny D.A., McCarty K.S., Cox E.B., et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46 (1986) 5419-5425
14. McClelland R.A., Finlay P., Walker K.J., et al. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res 50 (1990) 3545-3550
15. Teo P., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36 (1996) 291-304
16. Lin J.C., Chen K.Y., Wang W.Y., et al. Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: Relationship to distant metastasis and survival. J Clin Oncol 19 (2001) 2607-2615
17. Tse K.P., Tsang N.M., Chen K.D., et al. MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res 13 (2007) 6320-6326
18. Shapira M., Ben-Izhak O., Linn S., et al. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 103 (2005) 1336-1346
19. Signoretti S., Di Marcotullio L., Richardson A., et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 110 (2002) 633-641
20. Nakayama K.I., and Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol 16 (2005) 323-333
21. Masuda T.A., Inoue H., Sonoda H., et al. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: Modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62 (2002) 3819-3825
22. Yokoi S., Yasui K., Mori M., et al. Amplification and overexpression of Skp2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Am J Pathol 165 (2004) 175-180
23. Knight J.S., Sharma N., and Robertson E.S. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci USA 102 (2005) 18562-18566
24. Knight J.S., Sharma N., and Robertson E.S. SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol Cell Biol 25 (2005) 1749-1763